The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
FGF21 Regulates Sweet and Alcohol Preference
Open accessAbstract
Fibroblast growth factor 21 (FGF21) is a hormone induced by various metabolic stresses, including ketogenic and high-carbohydrate diets, that regulates energy homeostasis. In humans, SNPs in and around the FGF21 gene have been associated with macronutrient preference, including carbohydrate, fat, and protein intake. Here we show that FGF21 administration markedly reduces sweet and alcohol preference in mice and sweet preference in cynomolgus monkeys. In mice, these effects require the FGF21 co-receptor β-Klotho in the central nervous system and correlate with reductions in dopamine concentrations in the nucleus accumbens. Since analogs of FGF21 are currently undergoing clinical evaluation for the treatment of obesity and type 2 diabetes, our findings raise the possibility that FGF21 administration could affect nutrient preference and other reward behaviors in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly to its regulation of nutrient homeostasis, FGF21 production by the liver is also increased in response to alcohol intake132,133, and administration of FGF21 suppresses alcohol intake122,134.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [122]
In the citing paper
“FGF21 signals to the CNS and consequently suppresses simple-sugar intake and sweet-taste preference22,122, but not protein or lipid intake22,84.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [122]
In the citing paper
“Pharmacological administration of FGF21 decreases plasma glucose and lipid levels, improves insulin and leptin sensitivity, decreases hepatic steatosis, increases energy expenditure [[131], [132], [133], [134], [135], [136]], and decreases sugar and alcohol intake in mice [[137], [138], [139], [140], [141], [142]].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [138]
In the citing paper
“several recent studies confirmed that hepatic FGF21 increases in response to other nutritional stimuli, including conditions of macronutrient imbalance [152], and in response to alcohol intake [138,140,153].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [138]
In the citing paper
“Excess simple sugar intake increases plasma FGF21 levels in humans and rodents [137,138].”
From Hepatokines and metabolism: Deciphering communication from the liver (2021) · cites this paper as [138]
In the citing paper
“FGF21 also regulates sweet taste preference in primates and humans.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [125]
In the citing paper
“Interestingly, FGF21 also suppresses the intake of noncaloric sweeteners (125, 133).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [125]
In the citing paper
“Interestingly, administering recombinant FGF21 (116) or the overexpression of FGF21 (125) significantly reduced alcohol preference but not plasma ethanol concentrations.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [125]
In the citing paper
“When an FGF21 analog, PF-05231023, was administered to monkeys, they rapidly and significantly reduced their saccharin intake (125).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [125]
In the citing paper
“While FGF21 decreases alcohol intake, it should be noted that the effect on alcohol preference is impacted by the fact that FGF21 administration also increases total fluid intake through increased water intake in the presence of alcohol (125).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [125]
In the citing paper
“exogenous FGF21 treatment reduces the consumption of sweet foods and alcohol while alternatively increasing the consumption of protein”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [179]
In the citing paper
“the inhibition of saccharin was reproduced in monkeys treated with an FGF21 analog”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [179]
In the citing paper
“FGF21 acts in the brain, via Klb, to suppress sweet and alcohol intake”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [179]
In the citing paper
“This effect on sweet intake could be reproduced by exogenous FGF21 administration in control mice, but not mice lacking Klb in the brain.”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [179]
In the citing paper
“transgenic FGF21 overexpression reduced sucrose, saccharin, and alcohol intake”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [179]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
lmerTest Package: Tests in Linear Mixed Effects Models
Kuznetsova, A., Brockhoff, P. B., & Christensen, R. H. B. (2017) · Journal of Statistical Software · doi:10.18637/jss.v082.i13 · Cited by 24,346
The mouse brain in stereotaxic coordinates
Konsman, J. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 16,796
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
nlme : Linear and nonlinear mixed effects models
DebRoy, S. (2006) · Medical Entomology and Zoology · Cited by 10,009
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 2×
“Two-bottle preference assays with water and either 3% sucrose or 0.2% saccharin (Krishnan et al., 2007; Tordoff and Bachmanov, 2003) were performed using wild-type (WT) and Fgf21-transgenic (Tg) mice expressing supraphysiological con- centrations of FGF21 (Inagaki et al., 2007).”
InfluentialInagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Self-citationBadman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Can, A., Dao, D. T., Terrillion, C. E., Piantadosi, S. C., Bhat, S., & Gould, T. D. (2011) · Journal of Visualized Experiments · doi:10.3791/3769 · Cited by 691
Can, A., Dao, D. T., Arad, M., Terrillion, C. E., Piantadosi, S. C., & Gould, T. D. (2011) · Journal of Visualized Experiments · doi:10.3791/3638 · Cited by 628
FGF21 regulates metabolism and circadian behavior by acting on the nervous system
Bookout, A. L., de Groot, M. H. M., Owen, B. M., Lee, S., Gautron, L., Lawrence, H. L., Ding, X., Elmquist, J. K., Takahashi, J. S., Mangelsdorf, D. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3249 · Cited by 545
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 342
Reduced adiposity attenuates FGF21 mediated metabolic improvements in the Siberian hamster
Lewis, J. E., Samms, R. J., Cooper, S., Luckett, J., Perkins, A. C., Adams, A. C., Tsintzas, K., & Ebling, F. J. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-03607-x · Cited by 11
Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis
Zangerolamo, L., Carvalho, M. U. W. B. D., Velloso, L. A., & Barbosa, H. C. L. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176248 · Cited by 11
Wu, C.-T., Magaña, D. G., Roshgadol, J., Tian, L., & Ryan, K. K. (2024) · Appetite · doi:10.1016/j.appet.2024.107673 · Cited by 11
Parsing the Potential Neuroendocrine Actions of FGF21 in Primates
Gillum, M. P. (2018) · Endocrinology · doi:10.1210/en.2018-00208 · Cited by 9
Walia, P., Ghosh, A., Singh, S., & Dutta, A. (2022) · Brain Sciences · doi:10.3390/brainsci12040445 · Cited by 10
Uncoupling Protein-1 Modulates Anxiety-Like Behavior in a Temperature-Dependent Manner
Sideromenos, S., Gundacker, A., Nikou, M., Oberle, R., Horváth, O., Stöhrmann, P., Partonen, T., & Pollak, D. D. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2509-21.2022 · Cited by 11
New insights into the inter-organ crosstalk mediated by ChREBP
Carbinatti, T., Régnier, M., Parlati, L., Benhamed, F., & Postic, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1095440 · Cited by 13
ChREBP refines the hepatic response to fructose to protect the liver from injury
Hall, A. M., & Finck, B. N. (2017) · Journal of Clinical Investigation · doi:10.1172/jci95008 · Cited by 10
Psychology and Pathophysiological Outcomes of Eating
Takada, A., & Himmerich, H. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.92917 · Cited by 10
Dâmaso, A. R., Masquio, D. C. L., Campos, R. M. D. S., Corgosinho, F. C., & Cercato, C. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15251 · Cited by 15
Non-invasive tests for MetALD and alcohol-related liver disease
Johansen, S., Thiele, M. S., & Krag, A. A. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101569 · Cited by 10
Andrés-Hernando, A., Orlicky, D. J., García, G., Loetz, E. C., Montoya, R., Kumar, V., Effinger, D. P., Kuwabara, M., Bae, S., Lorenzo-Rebenaque, L., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01402-x · Cited by 9
Lanng, A. R., Gasbjerg, L. S., Sucksdorff, A. I. F., Svenningsen, J. S., Vilsbøll, T., Gillum, M. P., & Knop, F. K. (2024) · Alcohol · doi:10.1016/j.alcohol.2024.08.001 · Cited by 9
Ruiz-Padilla, A. J., Morales-Hernandez, G., Ruíz‐Noa, Y., Alonso‐Castro, Á. J., Lazo-de-la-Vega-Monroy, M.-L., Preciado‐Puga, M. D. C., Rangel-Salazar, R., & Ibarra‐Reynoso, L. D. R. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0546 · Cited by 9
Solomon, T. P. J., Carter, S., Haus, J. M., Karstoft, K., von Holstein‐Rathlou, S., Nielsen, M. S., & Gillum, M. P. (2022) · PeerJ · doi:10.7717/peerj.12755 · Cited by 10
The Sweetest Thing: Regulation of Macronutrient Preference by FGF21
Adams, A. C., & Gimeno, R. E. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.013 · Cited by 8
Yen, H., Hsieh, S., Chen, C., Yang, W., Lee, P., Lin, M., Chen, C., & Yang, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-62395-z · Cited by 9
Sex Differences in Ketogenic Diet Response Reveal Gonadal Hormone Interaction With FGF21 in Mice
Zhang, Y., Cochran, J. D., Souvenir, R., Tai, W. C., Xia, R., Gladwin, B. S., Barton, N. B., Pereira, R. O., & Abel, E. D. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf131 · Cited by 8
Self-citationHo, M., Zhang, C., Moon, I., Biernacka, J. M., Coombes, B. J., Ngo, Q., Skillon, C., Skime, M. K., Oesterle, T., Croarkin, P. E., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101798 · Cited by 8
Sostre‐Colón, J., Gavin, M. J., Santoleri, D., & Titchenell, P. M. (2022) · Endocrinology · doi:10.1210/endocr/bqac035 · Cited by 7
Geidl, B., Hochuli, M., Spinas, G. A., & Gerber, P. A. (2022) · Nutrients · doi:10.3390/nu14194169 · Cited by 9
Бажан, Н. М., Jakovleva, T., Kazantseva, A. Y., Костина, Н. Е., Orlov, P. E., Balybina, N., Baranov, K. O., & En, M. (2023) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vjgb-23-40 · Cited by 9
Müller, C. P. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112521 · Cited by 8
Self-citationRepression of the ERRγ-CYP2E1 pathway by FGF4 mitigates alcohol-associated liver injury
Wang, L., Dong, W., Fan, L., Kong, H., Liang, S., Huang, Z., Chen, J., Zhi, S., Xu, S., Qiu, Q., et al. (2025) · Hepatology · doi:10.1097/hep.0000000000001282 · Cited by 7
Neuroendocrinology meets addiction: Emerging pharmacotherapies on the horizon
Loftén, A., Farokhnia, M., Vendruscolo, L. F., & Leggio, L. (2025) · Journal of Internal Medicine · doi:10.1111/joim.70021 · Cited by 7
Wu, C.-T., Larson, K. R., Sims, L. C., & Ryan, K. K. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114368 · Cited by 7
Roles of FGF21 and irisin in obesity-related diabetes and pancreatic diseases
Xie, T., & Leung, P. S. (2020) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000039 · Cited by 7
Nielsen, M. S., Ritz, C., Chenchar, A., Bredie, W. L. P., Gillum, M. P., & Sjödin, A. M. (2021) · Nutrients · doi:10.3390/nu13113840 · Cited by 7
FGF21 response to sucrose is associated with BMI and dorsal striatal signaling in humans
Alves, J. M., Yunker, A. G., LUO, S. H., Jann, K., ANGELO, B. C., DEFENDIS, A. W., Pickering, T. A., Smith, A., Monterosso, J. R., & Page, K. A. (2022) · Obesity · doi:10.1002/oby.23432 · Cited by 7
Self-citationSousa‐Coelho, A. L. D., Rodríguez‐Rodríguez, R., Softic, S., Jonker, J. W., & Relat, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1253675 · Cited by 7
Yan, Y., Lian, Y., Li, Z., Zhang, B., Liu, P., & Huang, G. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1479699 · Cited by 7
FGF21 analogue PF-05231023 on alcohol consumption and neuronal activity in the nucleus accumbens
Cooley, B. J., Brown, C., Choi, E. A., Heller, W. A., LIM, A., Lawrence, A. J., Haber, P., McNally, G. P., & Millan, E. Z. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02133-z · Cited by 6
Carroll, H. A., Chen, Y., Templeman, I., James, L. J., Betts, J. A., & Trim, W. V. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235557 · Cited by 6
Diaz, P. M., Vannier, A., Joshi, A. D., Mahle, R. E., Przybyszewski, E. M., Corey, K. E., Chung, R. T., Luther, J., Goodman, R. P., & Schaefer, E. A. K. (2023) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000585 · Cited by 6
Gehring, J., Azzout‐Marniche, D., Chaumontet, C., Piedcoq, J., Gaudichon, C., & Even, P. C. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00246.2021 · Cited by 7
Zink, A., Priller, J., & Prigione, A. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.02.005 · Cited by 6
The role of FGF21 in the metabolic adjustments required for exercise capacity
Abe, L., & Dantzer, R. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123940 · Cited by 5
Korkmaz, D., Konya, P. Ş., & Demirtürk, N. (2022) · Turkish Journal of Parasitology · doi:10.4274/tpd.galenos.2022.14633 · Cited by 5
Briand, F., Dubroca, C., Wettstein, G., Grasset, E., Breyner, N. M., Bigot, C., Assaly, R., Broqua, P., & Sulpice, T. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177945 · Cited by 5
Herms, Q., Gratacós‐Ginès, J., & Pose, E. (2025) · Gastroenterology report · doi:10.1093/gastro/goaf088 · Cited by 5
Rama, K., Jahagirdar, V., & Sanyal, A. J. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s560034 · Cited by 6
Pérez-Gutiérrez, A. M., Carmona, R., Loucera, C., Cervilla, J. A., Gutiérrez, B., Molina, E., López-López, D., Pérez-Florido, J., Zarza-Rebollo, J. A., López‐Isac, E., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02609-2 · Cited by 5
Nielsen, M. S., Søberg, S., Schmidt, J. B., Chenchar, A., Sjödin, A. M., & Gillum, M. P. (2021) · PeerJ · doi:10.7717/peerj.11174 · Cited by 5
Basolo, A., Hollstein, T., Shah, M. H., Walter, M. F., Krakoff, J. A., Votruba, S. B., & Piaggi, P. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab204 · Cited by 6
Gijbels, A., Schutte, S., Esser, D., Michielsen, C. C. J. R., Siebelink, E., Mars, M., Mensink, M., & Afman, L. A. (2022) · Nutrients · doi:10.3390/nu14235061 · Cited by 5
Kuo, Y., Tsai, H.-Y., Kuo, Y., Tzeng, S., Chen, P.-S., Hsu, P., Lin, Y., & Chen, P. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121900 · Cited by 5
Wu, G., Liu, Y., Liu, Y., Zhang, L., Zhao, H., Liu, L., Zhao, C., & Feng, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.189 · Cited by 5
Doridot, L., Hannou, S. A., Krawczyk, S. A., Tong, W., Kim, M.-S., McElroy, G. S., Fowler, A. J., Astapova, I. I., & Herman, M. A. (2021) · Nutrients · doi:10.3390/nu13103642 · Cited by 5
Fibroblast growth factor 21 signaling: The liver in focus
Mahlapuu, M., & Marschall, H. (2016) · Hepatology · doi:10.1002/hep.28591 · Cited by 5
Brain amino acid sensing for organismal amino acid homeostasis
Tsang, A. H. K., Samson, L., & Blouet, C. (2025) · Open Biology · doi:10.1098/rsob.250092 · Cited by 4
Meng, J., Chen, X., & Zhu, Y. (2025) · Endocrinology · doi:10.1210/endocr/bqaf176 · Cited by 4
Negative feedback regulation of alcohol ingestion through the FGF21-PVH oxytocin-VTA dopamine system
Matsui, S., Takahashi, Y., Morioka, S., Ozawa, T., Kanayama, S., Iwama, H., Geng, L., Umemoto, K., Oguri, Y., Tsuzuki, S., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2525172122 · Cited by 4
Insights into the role of FGF21 in coronary heart disease
Zhang, Q.-Y., & Liu, H. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136911 · Cited by 4
Diagnosis and Management of Early Stages of ALD
Gratacós‐Ginès, J., Alvarado‐Tápias, E., Aguado, D. M., López‐Pelayo, H., Bataller, R. A., & Pose, E. (2025) · Seminars in Liver Disease · doi:10.1055/a-2541-2892 · Cited by 4
Fibroblast growth factor 19 stimulates water intake
Bedoya, J. U., Chavey, C., Desandré, G., Meunier, L., Dupuy, A., Dopeso‐Reyes, I. G., Tordjmann, T., Assénat, E., Hibner, U., & Grégoire, D. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101483 · Cited by 5
Genetic determinants of beverage consumption: Implications for nutrition and health
Cornelis, M. C. (2019) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2019.03.001 · Cited by 4
Protein Decoys, Alcohol, and Energy Intake: Testing a Mechanistic‐Ecological Model
Grech, A. L., Simpson, S. J., & Raubenheimer, D. (2026) · Obesity Reviews · doi:10.1111/obr.70138 · Cited by 3
The role of fibroblast growth factor 21 in diabetes and metabolic dysfunction
Jaiswal, A., Nigam, C., Singh, G. N., & Gautam, A. K. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12132-y · Cited by 3
Xu, J., Wu, F., Li, Y., Wang, F., Lin, W., Song, Q., Li, H., Fan, Y., Li, H., Chen, L., et al. (2021) · BMC Neuroscience · doi:10.1186/s12868-021-00676-7 · Cited by 4
Identificación del fenotipo ahorrador para la personalización del manejo del sobrepeso y la obesidad
Fernando Carrasco, N., & Navarro, G. N. C. (2022) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2022.03.006 · Cited by 6
Frayling, T. M., Beaumont, R. N., Jones, S. E., Yaghootkar, H., Tuke, M. A., Ruth, K. S., Casanova, F., West, B., Locke, J. M., Sharp, S. A., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/214700 · Cited by 3
Stevanović, D., Hebert, A. J., Desai, B. N., Singhal, G., Adams, A. C., Flier, J. S., & Maratos–Flier, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.27.921361 · Cited by 3
Ecology, Protein Leverage, and Public Health
Raubenheimer, D., & Simpson, S. J. (2022) · Wiley eBooks · doi:10.1002/9781119695257.ch6 · Cited by 3
Zhang, X., Li, Z., Wang, S., & Chen, Y. (2025) · Nutrients · doi:10.3390/nu17071179 · Cited by 2
Janzi, S., Ramne, S., Kou, M., Lu, X., Stubbendorff, A., Ke, C., Borné, Y., Qi, L., & Sonestedt, E. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.08.020 · Cited by 2
Interorgan crosstalk in metabolic dysfunction-associated steatotic liver disease
Yang, R., Fang, Z., He, F., & Wang, L. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003927 · Cited by 2
The spatiotemporal dynamics of MAMs: mechanisms, pathologies, and therapeutic rewiring
Xu, D., Huang, Y., Zhang, X., Liu, B., Wang, M., Li, Y., & Peng, Z. (2026) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-026-00887-y · Cited by 2
Fibroblast Growth Factor 21 as a Regulator of Energy Metabolism in the Liver and Adipose Tissue
Matikainen, N., & Söderlund, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816093-0.00013-6 · Cited by 2
Kang, P., Zhang, Y., Zeng, D., Liu, D., Han, R., Lu, Y.-W., Cheng, D., Wang, Q., Liu, S., Wu, L., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0390 · Cited by 2
Self-citationMacronutrient intake: Hormonal controls, pathological states, and methodological considerations
Przybysz, J. T., DiBrog, A. M., Kern, K. A., Mukherjee, A., Japa, J. E., Waite, M. H., & Mietlicki‐Baase, E. G. (2022) · Appetite · doi:10.1016/j.appet.2022.106365 · Cited by 2
Pohlhammer, J., Heinzl, M. W., Klammer, C., Feldbauer, R., Rosenberger, K., Resl, M., Wagner, T., Obendorf, F., Egger-Salmhofer, M., Dieplinger, B., et al. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17614 · Cited by 1
Εvangelou, Ε., Gao, H., Chu, C., Ntritsos, G., Blakeley, P., Butts, A. R., Pazoki, R., Suzuki, H., Koskeridis, F., Yiorkas, A. M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/453332 · Cited by 2
A Polymorphism in the FGF21 Gene is a Novel Risk Variant for Metabolic-Associated Steatohepatitis
Elsayed, A. (2020) · The Sydney eScholarship Repository (The University of Sydney) · Cited by 2
Le, T. D. V., Fathi, P. A., Watters, A. B., Ellis, B. J., Bozadjieva-Kramer, N., Perez, M. B., Sullivan, A. I., Rose, J. P., Baggio, L. L., Koehler, J. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.03.522509 · Cited by 2
Murad, M. A. H., Islam, M. M., Suchana, N. J., Rashid, M. M. O., Ahmed, F., & Hussain, F. (2025) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2025.100677 · Cited by 1
Sun, S., Li, M., Ma, J., He, K., Wang, L., Li, C., Liu, X., Zhang, S., Yin, T., Yang, M., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03685-z · Cited by 2
Cronjé, H. T., Hu, S., Gurrell, R., Vujković, M., Larsson, S. C., Mason, R., Butt, R. P., & Gill, D. (2026) · BMC Medicine · doi:10.1186/s12916-026-04807-x · Cited by 3
Barros, H. D. D. F. Q., Casagrande, B. P., Araújo, D. D., Mutran, T. A. J., Telles, M. M., Estadella, D., & Pisani, L. P. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10038-5 · Cited by 3
Macronutrient mixtures and interactions in health and disease
Simpson, S. J., Couteur, D. G. L., Small, L., Brandon, A. E., & Raubenheimer, D. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01266-5 · Cited by 1
The liver-brain axis, from its function to preventive therapeutic strategies in diseases
Chen, Y., Xu, S., & Sun, T. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1858091 · Cited by 1
Holleboom, A. G., & Schattenberg, J. M. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101957 · Cited by 1
Wali, J. A., Ramos-Nieves, J. M., Binia, A., & van der Beek, E. M. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100713 · Cited by 1
FGF21 influences a 'sweet tooth' in mice
Geach, T. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.8 · Cited by 1
A Framework for Uncovering the Roles of Calories and Macronutrients in Health and Aging
Solon‐Biet, S. M., Wahl, D., Raubenheimer, D., Couteur, D. G. L., Simpson, S. J., & Cogger, V. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00008-7 · Cited by 1
Denisova, E. I., Savinkova, M. M., & En, M. (2021) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vj21.076 · Cited by 2
Li, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15793-6.00001-9 · Cited by 1
Liangpunsakul, S., & Leggio, L. (2024) · Alcohol · doi:10.1016/j.alcohol.2024.12.001 · Cited by 1
FGF21 Conducts a Metabolic Orchestra and Fat Is a Key Player
Whittle, A. J. (2016) · Endocrinology · doi:10.1210/en.2016-1193 · Cited by 1
Metabolic Responses to Energy-Depleted Conditions
SUZUKI, T., Komatsu, T., Shibata, H., & Inagaki, T. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100391 · Cited by 2
Wu, C.-T., Magaña, D. G., Roshgadol, J., Tian, L., & Ryan, K. K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.21.600074 · Cited by 1
Cronjé, H. T., Hu, S., Gurrell, R., Vujković, M., Larsson, S. C., Mason, R., Butt, R., & Gill, D. (2025) · medRxiv · doi:10.1101/2025.11.15.25340305 · Cited by 1
The Sweet Path to Metabolic Demise: Fructose and Lipid
Herman, S. A., & Samuel, V. T. (2016)
FGF-21 levels in polyuria-polydipsia syndrome
Refardt, J. C., Sailer, C. O., Winzeler, B. F., Mj, B., Chifu, I. O., Schnyder, I., Faßnacht, M., Fenske, W. K., Christ‐Crain, M., & _, _. (2018) · Endocrine Connections · doi:10.1530/ec-18-0469
Restriction of essential amino acids dictates the systemic response to dietary protein dilutionPreprint
Yap, Y. W., Rusu, P. M., Chan, A. Y., Fam, B. C., Jungmann, A., Solon‐Biet, S. M., Barlow, C. K., Creek, D. J., Huang, C., Schittenhelm, R. B., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/848143
Rôle des hépatokines dans le dialogue inter-organes en physiologie et physiopathologie
Pacheco, A., & Postic, C. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.04.008
Yunker, A. G., Alves, J. M., LUO, S. H., ANGELO, B. C., DEFENDIS, A. W., Pickering, T. A., Jann, K., Monterosso, J. R., & Page, K. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.29.446318
The hormone Fibroblast Growth Factor 19 stimulates water intakePreprint
Bedoya, J. U., Carine Chavey, A., Meunier, L., Desandré, G., Dupuy, A., Dopeso‐Reyes, I. G., Tordjmann, T., Assénat, E., Hibner, U., & Grégoire, D. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.26.466031
A dual mechanism fully blocks ethanol relapse: Role of vagal innervation
Quintanilla, M. E., Ezquer, F. E., Morales, P., Santapau, D., Ezquer, M., Herrera‐Marschitz, M., & Israel, Y. (2022) · Addiction Biology · doi:10.1111/adb.13140 · Cited by 1
Development of a fibroblast growth factor 21 assay
Tamassia, G. V. (2017) · doi:10.32469/10355/62371
Metadata
- Authors
- Talukdar, S., Owen, B. M., Song, P., Hernandez, G., Zhang, Y., Zhou, Y., Scott, W. T., Paratala, B., Turner, T., Smith, A., Bernardo, B., Müller, C. P., Tang, H., Mangelsdorf, D. J., Goodwin, B., & Kliewer, S. A.
- Affiliations
- Pfizer (United States) (US)
- The University of Texas Southwestern Medical Center (US)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Mangelsdorf, David J.
- Kliewer, Steven A.
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2016-02
- Volume
- 23
- Issue
- 2
- Pages
- 344-349
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC4749404
- OpenAlex
- W2198244887
- Cited by
- 342
- References
- 31
- Citations by year
- 2026: 25 · 2025: 31 · 2024: 24 · 2023: 30 · 2022: 44 · 2021: 36 · 2020: 44 · 2019: 27 · 2018: 28 · 2017: 30 · 2016: 23
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 374 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Welch Foundation (I-1275, I-1558)
- Wellcome Trust
- Royal Society (105545/Z/14/Z)
- National Institutes of Health (5P50 CA70907-16, NNX11AC54G, R01CA152301, R01DK067158)
- Deutsche Forschungsgemeinschaft (MU 2789/8-1)
- Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
- Howard Hughes Medical Institute
- Ford Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Nursing › Nutrition and Dietetics › Biochemical Analysis and Sensing Techniques
- Keywords
- FGF21, sweet taste preference, alcohol preference, macronutrient preference, β-Klotho, dopamine, nucleus accumbens, reward behavior, energy homeostasis, obesity, type 2 diabetes, FGF21 analogs
- MeSH terms
- Alcohols, Animals, Haplorhini, Central Nervous System, Dopamine, Fibroblast Growth Factors, Food Preferences, Humans, Male, Mice, Inbred C57BL, Saccharin, Taste, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
